266 related articles for article (PubMed ID: 21343876)
1. Prognostic significance of preoperative imaging in recipients of living donor liver transplantation for hepatocellular carcinoma.
Sugimachi K; Shirabe K; Taketomi A; Soejima Y; Iguchi T; Takeishi K; Toshima T; Aishima S; Tajima T; Maehara Y
Transplantation; 2011 Mar; 91(5):570-4. PubMed ID: 21343876
[TBL] [Abstract][Full Text] [Related]
2. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation.
Li C; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Wei YG
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):366-9. PubMed ID: 20688599
[TBL] [Abstract][Full Text] [Related]
3. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation.
Shirabe K; Aishima S; Taketomi A; Soejima Y; Uchiyama H; Kayashima H; Ninomiya M; Mano Y; Maehara Y
Br J Surg; 2011 Feb; 98(2):261-7. PubMed ID: 21072849
[TBL] [Abstract][Full Text] [Related]
5. Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria.
Woo HY; Jang JW; Choi JY; You CR; Jeong SW; Bae SH; Yoon SK; Lee YS; Kim DG
Liver Int; 2008 Sep; 28(8):1120-8. PubMed ID: 18492023
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
Shin WY; Suh KS; Lee HW; Kim J; Kim T; Yi NJ; Lee KU
Liver Transpl; 2010 May; 16(5):678-84. PubMed ID: 20440777
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of living donor liver transplantation for patients with hepatocellular carcinoma].
Jiang XZ; Yan LN; Li B; Wen TF; Zeng Y; Zhao JC; Wang WT; Yang JY; Xu MQ; Chen ZY; Ma YK; Li FG; Gong G
Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):3-6. PubMed ID: 18226334
[TBL] [Abstract][Full Text] [Related]
8. Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation.
Taketomi A; Fukuhara T; Morita K; Kayashima H; Ninomiya M; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Shirabe K; Maehara Y
Ann Surg Oncol; 2010 Sep; 17(9):2283-9. PubMed ID: 20204531
[TBL] [Abstract][Full Text] [Related]
9. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
10. Adoption of new selection criteria on living donor liver transplantation for hepatocellular carcinoma and their impact on the outcome.
Azzam AZ; Tanaka K
Hepatogastroenterology; 2011; 58(112):1873-6. PubMed ID: 22234056
[TBL] [Abstract][Full Text] [Related]
11. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series.
Sugawara Y; Tamura S; Makuuchi M
Dig Dis; 2007; 25(4):310-2. PubMed ID: 17960065
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables.
Kornberg A; Küpper B; Tannapfel A; Katenkamp K; Thrum K; Habrecht O; Wilberg J
Eur J Surg Oncol; 2010 Mar; 36(3):275-80. PubMed ID: 19857941
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
Hwang S; Lee SG; Joh JW; Suh KS; Kim DG
Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
[TBL] [Abstract][Full Text] [Related]
14. Experience of the transplant team is an important factor for posttransplant survival in patients with hepatocellular carcinoma undergoing living-donor liver transplantation.
Majeed TA; Wai CT; Rajekar H; Lee KH; Wong SY; Leong SO; Singh R; Tay KH; Chen J; Tan KC
Transplant Proc; 2008 Oct; 40(8):2507-9. PubMed ID: 18929781
[TBL] [Abstract][Full Text] [Related]
15. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
[TBL] [Abstract][Full Text] [Related]
16. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center.
Lee SG; Hwang S; Moon DB; Ahn CS; Kim KH; Sung KB; Ko GY; Park KM; Ha TY; Song GW
Liver Transpl; 2008 Jul; 14(7):935-45. PubMed ID: 18581465
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
Arikan C; Kilic M; Nart D; Ozgenc F; Ozkan T; Tokat Y; Yagci RV; Aydogdu S
Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586
[TBL] [Abstract][Full Text] [Related]
18. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
19. The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma.
Yokoi H; Isaji S; Yamagiwa K; Tabata M; Nemoto A; Sakurai H; Usui M; Uemoto S
J Hepatobiliary Pancreat Surg; 2006; 13(2):123-30. PubMed ID: 16547673
[TBL] [Abstract][Full Text] [Related]
20. Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Hara Y; Waguri N; Suda T; Aoyagi Y; Hatakeyama K
Transplant Proc; 2006 Dec; 38(10):3636-9. PubMed ID: 17175353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
